Imago Biosciences Inc (IMGO) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMGO quarterly Balance Sheets →
A period-by-period view of the balance sheet from Imago Biosciences Inc to helps clarify how Dec 31 2021's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
Assets
Cash & cash equivalent11.23
Combined Cash+Investments Total (filer-reported)216.07
Short-term Investments, Total206.18
Cash & Short-term Investments217.00
Prepaid Expense And Other Assets Current3.89
Total Current Assets221.30
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent3.00
Total Assets224.79
Liabilities
Accounts Payable, Current AC3.46
Accrued Liabilities, Current AC6.63
Total Current Liabilities10.09
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities10.09
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock327.39
Retained Earnings / Accumulated Deficit-112.65
Other Equity-0.04
Common Stockholder's Equity214.69
Total Stockholder's Equity214.69
Liabilities & Stockholder's Equity224.79
4 historic quarters locked

Sign in to unlock the full Imago Biosciences Inc balance sheet history.

About Imago Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-22-023883

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License